News | Neuro Imaging | January 02, 2019

First Arterial and Venous Atlas of the Human Brain Released

Atlas contains MRI images of the brain showing blood vessels normally difficult to view noninvasively

First Arterial and Venous Atlas of the Human Brain Released

January 2, 2019 — Imagine an atlas containing an image bank of the blood vessels of the brain taken from healthy humans which can be used as a reference to target alterations among those with cerebral vascular degeneration. That key to improving the diagnosis of neurodegenerative diseases and to understanding their origin is now within reach as the result of the work of a team of Université de Sherbrooke researchers that is gaining international attention.

Kevin Whittingstall, a research professor at the faculty of medicine and health sciences (FMSS) of the Université de Sherbrooke and at the Centre de recherche du CHUS, has dedicated years to develop noninvasive imaging techniques to view the structure and functioning of the human brain. His doctoral student, Michaël Bernier, who is now a postdoctoral fellow at Harvard Medical School, developed a new segmentation software tool. Together, they were able to extract images of blood vessels in the brain that are normally difficult to view using noninvasive procedures. Thanks to these images, they have documented what they call the world's most complete arterial and venous atlas of the human brain. Stephen Cunnane, a professor and researcher at the FMSS and at the Centre de recherche sur le vieillissement, also collaborated in this discovery.

"We spend 10 minutes in a magnetic resonance imaging (MRI) session to take two images of the patient's brain," explained Whittingstall. "The first image targets the arteries by measuring blood velocity. The second image measures magnetic interference, thus enabling the veins to be viewed. Our images are so precise that they enable us to quantify the structure, length and diameter of different blood vessels in each region of the brain. Michaël then assembles them using computer software which combines mathematics with image processing before obtaining an arteriovenous tree that is unique to each patient."

The brain atlas can thus be compared to a fingerprint databank. The team can compare the patient's vascular tree with images taken from healthy brains and determine whether there are subtle variations. If so, the team will try to determine where they originate. Are they from a brain concussion or from the onset of Alzheimer's disease, and so on?

Last November, this innovation made the front page of Human Brain Mapping.1 The team is already being solicited by researchers in other countries who wish to use the atlas in clinical studies on brain concussions and stroke (cerebrovascular accidents).

For more information: www.usherbrooke.ca

Reference

1. Bernier M., Cunnane S.C., Whittingstall K. The morphology of the human cerebrovascular system. Human Brain Mapping, Sept. 28, 2018. https://doi.org/10.1002/hbm.24337

Related Content

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Two brain metastases from primary lung cancer are contrast enhanced in the brain of a 61-year-old male. Speakers at AHRA 2019 will state that ProHance and other macrocyclic MR agents present a very low risk to patients. Images courtesy of Bracco

Feature | Contrast Media | July 18, 2019 | By Greg Freiherr
Macrocyclic contrast agents have the best safety profile of all the magnetic resonance (MR) contrast media that are n
AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
International Working Group Releases New Multiple Myeloma Imaging Guidelines

X-ray images such as the one on the left fail to indicate many cases of advanced bone destruction caused by multiple myeloma, says the author of new guidelines on imaging for patients with myeloma and related disorders. Image courtesy of Roswell Park Comprehensive Cancer Center.

News | Computed Tomography (CT) | June 17, 2019
An International Myeloma Working Group (IMWG) has developed the first set of new recommendations in 10 years for...
SyMRI Software Receives FDA Clearance for Use With Siemens MRI Systems
Technology | Magnetic Resonance Imaging (MRI) | June 14, 2019
SyntheticMR announced U.S. Food and Drug Administration (FDA) clearance for clinical use of its SyMRI Image and SyMRI...